Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02719288 · ClinicalTrials.gov registry record · NA
Peroneal and Achilles Tendon Repair Indications With CLARIX® CORD 1K
A NA study of Peroneal and Achilles Tendon Tears, sponsored by Amniox Medical.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 4
- Study locations
NCT02719288: Completed NA study of Peroneal and Achilles Tendon Tears, sponsored by Amniox Medical.
NCT02719288 is a NA study of Peroneal and Achilles Tendon Tears that has completed, run by Amniox Medical. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02719288, a NA study of Peroneal and Achilles Tendon Tears, has completed, sponsored by Amniox Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 4
- Study locations
Study Summary
Peroneal and Achilles tendon tears are common diseases that present challenges to surgeons due to tendon adhesion complications. Functional recovery is compromised by limiting post-operative range of motion, mobility, and can lead to considerable amount of post-operative pain for the patient. Amniotic membrane tissue has demonstrated clinical success as an anti-inflammatory and anti-scarring agent and promoting wound healing towards regeneration. Cryopreserved human amniotic membrane and umbilical cord (AM/UC) tissue in the form of CLARIX® CORD 1K has been used to treat over 5000 orthopedic patients. The investigators hypothesize that its use in peroneal and Achilles tendon surgical repair will enhance the overall functional recovery of the patient.
Conditions Studied
Interventions
- OTHER CLARIX® CORD 1K graft
Study Locations (4)
Arizona
- Banner Estrella Medical Center - Phoenix
- Banner Del Webb Medical Center - Sun City West
North Carolina
- OrthoCarolina Research Institute - Charlotte
Ohio
- Orthopedic Foot and Ankle Center - Westerville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2016-02-15 |
| Est. Completion | 2018-12-18 |
| Phase | NA |
What the finished NCT02719288 record still lists
NCT02719288 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Peroneal and Achilles Tendon Tears appearing as the primary indexed condition, and to 1 intervention - of which CLARIX® CORD 1K graft is the first listed.
NCT02719288 reports a single indexed study location in Arizona, North Carolina, Ohio.
Frequently Asked Questions
What is clinical trial NCT02719288 about?
NCT02719288 is a clinical study titled "Peroneal and Achilles Tendon Repair Indications With CLARIX® CORD 1K". Peroneal and Achilles tendon tears are common diseases that present challenges to surgeons due to tendon adhesion complications. Functional recovery is compromised by limiting post-operative range of motion, mobility, and can lead to considerable amount of post-operative pain for the patient. Amnio...
What is the current status of trial NCT02719288?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2016-02-15. Estimated completion is 2018-12-18.
What conditions does trial NCT02719288 study?
This clinical trial studies the following conditions: Peroneal and Achilles Tendon Tears.
What interventions are being tested in trial NCT02719288?
The interventions under investigation include: CLARIX® CORD 1K graft (OTHER).
Who is sponsoring clinical trial NCT02719288?
This trial is sponsored by Amniox Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02719288 being conducted?
This trial has 4 study locations across Arizona, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02719288's enrollment target sits among peer trials
64 1147th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI